-

Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye

Columbia University scientist recognized for his contributions to sustainability and improving environmental health

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that Adeyemi Adeleye, Ph.D., has received the Agilent 2024 Early Career Professor Award for his contribution to environmental health and sustainability, developing green analytical technologies, methods, or laboratory working environments. Dr. Adeleye is an assistant professor in the Department of Earth and Environmental Engineering at Columbia University.

The 2024 award focused on contributions to academic research in sustainability and green chemistry. Dr. Adeleye’s research focuses on improving environmental health and sustainability through green approaches, and specifically, using engineered nanoparticles made of earth-abundant, essential elements such as iron, sulfur, and silicon to remediate environmental matrices contaminated with persistent pollutants like arsenic, lead, and per- and polyfluoroalkyl substances (PFAS). Additionally, Dr. Adeleye is studying ways to combine remediation with carbon sequestration in soil to reduce the environmental impact of these approaches.

“I am deeply honored and grateful to receive this esteemed award, which recognizes my research group’s efforts and inspires us to continue striving for excellence,” said Dr. Adeleye. “Persistent environmental contaminants, like heavy metals, pose a significant threat to food safety and human health. "We will continue to expand our understanding of how heavy metals interact with engineered surfaces in natural environments, supporting our long-term goal of developing sustainable solutions to heavy metal contamination. The support from Agilent will undoubtedly help us achieve this important ambition.”

“Agilent is committed to advancing environmental sustainability and empowering innovation that accelerates the development of eco-friendly solutions by supporting researchers who are pioneering green analytical technologies and sustainable laboratory practices,” said Nahid Chalyavi, associate vice president of University Relations and External Research at Agilent. “This year’s award recipient, Dr. Adeleye, is at the forefront of integrating environmental chemistry, engineering, and material science. His research focuses on understanding the reactions between pollutants and reactive surfaces in environmental systems and applying this knowledge to remediate polluted environments.”

Dr. Adeleye’s research supports the effort of the US Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) to tackle the widespread occurrence of toxic heavy metals in crop-based foods through the “Closer-to-Zero” Initiative. The National Science Foundation (NSF) and the Centers for Disease Control and Prevention (CDC) have also supported his work.

The Agilent Early Career Professor Award is an annual program that recognizes and supports promising research from professors who, early in their careers, show outstanding potential for future research in areas of importance to the communities Agilent serves. This award underscores Agilent's commitment to furthering research through the company's products and services, financial support, and collaborative engagement by Agilent scientists and engineers. Further information about the program is available at Agilent.com.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas. Agilent will highlight expanded biomarker testing capabilities, continued progress in digital pathology adoption, and the evolving role of the Dako Omnis family of instruments as a founda...

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company’s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing so...

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

SANTA CLARA, Calif. & SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million. Biocare is a high-growth global pathology antibody leader, serving customers with a complementary portfolio of immunohistochemistry (IHC), in sit...
Back to Newsroom